Simultaneous Immediate and Delayed Hypersensitivity to Galcanezumab-Case Report

Contact Dermatitis. 2024 Dec 30. doi: 10.1111/cod.14747. Online ahead of print.

Peter Refki^{1

2}, Aude Belbézier^{1

2}, Marine-Alexia Lefevre^{3

4}, Marc Vocanson⁴, Amandine Mosnier⁴, Martine Pernollet⁵, Marie Tauber^{3

6}, Pauline Pralong^{1

2}

¹ Dermatology, Allergology and Photobiology Department, Grenoble University Hospital, Grenoble, France.
² Grenoble Alpes University, Grenoble, France.
³ CIRI, Centre International de Recherche en Infectiologie, Team Epidermal Immunity and Allergy, INSERM, Lyon, France.
⁴ Department of Dermatology and Allergy, Centre Hospitalier Universitaire de St Etienne, Saint-Priest-en-Jarez, France.
⁵ Laboratoire d'Immunologie, Pôle de Biologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
⁶ Clinical Immunology and Allergology Department, Lyon Sud University Hospital, Pierre Benite, France.

No abstract available

Keywords: Galcanezumab; calcitonin gene‐related peptide; delayed allergy; immediate allergy.

Publication types